![]() |
市场调查报告书
商品编码
1370634
医疗辐射检测市场规模(按类型(充气侦测器、闪烁体、固态)、按产品(个人剂量计、区域过程剂量计、表面污染监测仪)、最终用途 - 全球预测,2023-2032 年Medical Radiation Detection Market Size By Type (Gas-filled Detectors, Scintillators, Solid-State), By Product (Personal Dosimeters, Area Process Dosimeters, Surface Contamination Monitors), By End-use - Global Forecast, 2023-2032 |
2023年至2032年,全球医疗辐射检测市场的复合年增长率将达到7.4%。医疗设备和成像辐射领域不断增长的研究和开发为市场提供了支持。例如,2023年9月,一群科学家与美国能源部阿贡国家实验室合作,成功展示了一种新型探测器材料在探测高能量X射线散射图案方面的出色性能。即使在极高的 X 射线通量下,这种材料也表现出卓越的耐用性,并提供了具有成本效益的解决方案,使其成为基于同步加速器的 X 射线研究的宝贵资产。
随着该领域不断创新,重点是提高医疗程序的安全性和准确性,对更复杂、更有效率的辐射检测技术的需求将呈上升趋势。人们对研发的兴趣日益浓厚,正在推动医疗辐射检测市场的成长,最终有利于病患照护和医疗保健结果。
整个医疗辐射检测市场根据产品、最终用途和地区进行分类。
区域製程剂量计领域将在 2023 年至 2032 年间经历重大发展。这些专用设备对于监测和保护辐射密集环境(例如医疗机构和工业环境)中的个人至关重要。随着人们对工人和病人安全的日益重视,对精确可靠的区域过程剂量计的需求不断增加,使其成为医疗辐射检测市场份额的重要组成部分。
门诊手术中心部分从 2023 年到 2032 年将实现显着的复合年增长率。随着这些中心执行越来越多的放射学手术,确保患者和医疗保健专业人员的安全至关重要。因此,门诊手术中心对辐射检测设备的需求增加,在效率和患者护理是首要任务的环境中提供重要的保护和合规性。因此,不断增长的患者偏好和经济效益支持了门诊手术中心细分市场对医疗辐射检测市场需求的贡献。
欧洲医疗辐射检测市场从 2023 年到 2032 年将呈现可观的复合年增长率。这一增长可归因于严格的安全法规和医疗保健环境中辐射风险意识的不断增强。随着对患者和工作人员安全的关注,对准确、可靠的辐射检测解决方案的需求日益增加,特别是随着该地区推出的医疗诊断设备数量不断增加。
例如,2023 年 10 月,价值 3,200 万英镑的用于药物发现的开创性全身正子断层扫描 (PET) 影像平台亮相。这项开创性的倡议在英国尚属首次,是透过 Medicines Discovery Catapult (MDC)、医学研究委员会 (MRC) 之间的合作以及创新英国的支持而得以实现,所有这些都由 UKRI 基础设施基金资助。随着欧洲继续优先考虑辐射安全,该地区的医疗辐射检测市场正在持续成长。
Global Medical Radiation Detection Market will witness 7.4% CAGR between 2023 and 2032. The growing research and development in the field of radiation in medical devices and imaging supports the market. For instance, in September 2023, a team of scientists collaborating with the US Department of Energy's Argonne National Laboratory successfully demonstrated a new detector material's outstanding performance in detecting high-energy X-ray scattering patterns. This material exhibits remarkable durability even under extremely high X-ray flux and offers a cost-effective solution, making it a valuable asset for synchrotron-based X-ray research.
As the field continues to innovate with a focus on enhancing safety and accuracy in medical procedures, the demand for more sophisticated and efficient radiation detection technologies will record an upward trend. This growing interest in R&D is driving the medical radiation detection market growth, ultimately benefiting patient care and healthcare outcomes.
The overall Medical Radiation Detection Market is classified based on product, end-use, and region.
Area process dosimeters segment will undergo significant development from 2023 to 2032. These specialized devices are crucial for monitoring and safeguarding individuals in radiation-intensive environments, such as healthcare facilities and industrial settings. With a growing emphasis on worker and patient safety, the demand for precise and reliable area process dosimeters is on the rise, making them an essential component in the medical radiation detection market share.
Ambulatory surgery centers segment will register a notable CAGR from 2023 to 2032. As these centers perform a growing number of radiological procedures, ensuring the safety of patients and healthcare professionals is paramount. Consequently, the demand for radiation detection devices in ambulatory surgery centers has increased, providing a vital layer of protection and compliance in an environment where efficiency and patient care are top priorities. Therefore, the growing patient preference and economic benefits support the contribution of the ambulatory surgery centers segment in the medical radiation detection market demand.
Europe medical radiation detection market will showcase an appreciable CAGR from 2023 to 2032. This increase can be attributed to stringent safety regulations and growing awareness of radiation risks in healthcare settings. With a focus on patient and staff safety, there's a heightened need for accurate and reliable radiation detection solutions, especially with the rising number of medical diagnosis device launches in the region.
For instance, in October 2023, A pioneering total-body positron emission tomography (PET) imaging platform for drug discovery worth £32 million has been unveiled. This groundbreaking initiative, the first of its kind in the UK, has been made possible through collaboration between the Medicines Discovery Catapult (MDC), the Medical Research Council (MRC), and the support of Innovate UK, all funded by the UKRI Infrastructure fund. As Europe continues to prioritize radiation safety, the medical radiation detection market in the region is experiencing sustained growth.